EMPRA (EMPagliflozin and RAs in Kidney Disease)

Clinical trial NCT03078101 · COMPLETED

Trial details

NCT number: NCT03078101
Sponsor: Medical University of Vienna
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Kidney Disease Diabetes Mellitus, Type 2 Chronic Kidney Disease stage3 Chronic Kidney Disease stage4

Start date: 2017-04-15
Primary completion: 2019-06-18
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.